NCT05637710 - Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil | Biotech Hunter

Enrollment

754

Participants

Timeline

Start Date

March 31, 2026

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions

Allergic Rhinitis

Interventions

DRUG

Administration of investigation of Eurofarma drug

Participants randomized to this group will receive one (01) film-coated tablet of the investigational drug + one (01) levocetirizine placebo tablet, once a day, for seven (07) days.

DRUG

Administration of Comparator

Participants randomized to this group will receive one (01) levocetirizine 5mg tablet (Zina® 5mg) + one (01) FDC placebo tablet, once daily, for seven (07) days.

Trial Locations (1)

06696-000

Eurofarma Laboratorios S.A, São Paulo